Regulatory Disclosure Summary

Background and Context

This disclosure is in continuation of the company's previous disclosure dated 19th June 2025 (SPL/CS/SE/2025-26/26) regarding board approval to incorporate a limited liability company in the United States.

Subsidiary Incorporation Details

  • Name of Subsidiary: Sudarshan Industries Inc. (Sudarshan USA)
  • Date of Incorporation: Friday, 5th June 2026
  • Legal Structure: Limited Liability Company
  • Service Address: 8, The Green Ste R, Dover County, Kent - 19901, USA
  • Ownership Structure: 100% wholly-owned subsidiary

Share Subscription Details

  • Number of Shares Subscribed: 1,00,00,000 shares
  • Par Value per Share: US $0.00001
  • Total Investment Amount: US $100 (approximately ₹9,600)
  • Percentage of Paid-up Share Capital: 100.00%

Business Activities of Subsidiary

Sudarshan USA will carry on business activities including:

  • Buying, selling, manufacturing, processing, importing, and exporting
  • Pharmaceuticals, antibiotics, drugs, medicines, biological products
  • Neutraceuticals, healthcare products, ayurvedic and dietary supplements
  • Medicinal preparations, vaccines, pharma intermediates
  • Active Pharmaceutical Ingredients (APIs)
  • Chemicals, chemical products, chemical compounds including specialty chemicals
  • Wholesale and retail trade of all allied goods

Transaction Details

  • Related Party Transaction: No, the incorporation does not fall within related party transactions
  • Consideration Type: Cash consideration
  • Funding Mechanism: Remittance after obtaining necessary approval from Reserve Bank of India
  • Regulatory Route: Automatic route under Foreign Exchange Management (Non-debt Instruments) Rules, 2019 and Foreign Exchange Management (Overseas Investment) Regulations and Directions, 2022

Management Appointment

Mr. Sachin Mehta, Joint Managing Director, has been appointed as the First Director of Sudarshan USA.

Purpose and Strategic Rationale

The incorporation of Sudarshan USA will enable the company to enlarge its customer base in the USA market.

Financial Impact

The total investment amount is minimal at approximately ₹9,600, representing a negligible financial impact on the company's capital structure.